Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
Merck
Baxter
Julphar
Medtronic
Teva
Cerilliant
US Army

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018257

« Back to Dashboard

NDA 018257 describes TONOCARD, which is a drug marketed by Astrazeneca and is included in one NDA. Additional details are available on the TONOCARD profile page.

The generic ingredient in TONOCARD is tocainide hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tocainide hydrochloride profile page.
Summary for 018257
Tradename:TONOCARD
Applicant:Astrazeneca
Ingredient:tocainide hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018257

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength400MG
Approval Date:Nov 9, 1984TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength600MG
Approval Date:Nov 9, 1984TE:RLD:No

Expired US Patents for NDA 018257

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-002 Nov 9, 1984 ➤ Sign Up ➤ Sign Up
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-002 Nov 9, 1984 ➤ Sign Up ➤ Sign Up
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-001 Nov 9, 1984 ➤ Sign Up ➤ Sign Up
Astrazeneca TONOCARD tocainide hydrochloride TABLET;ORAL 018257-001 Nov 9, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Moodys
Covington
McKesson
Chinese Patent Office
Chubb
Accenture
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.